France amends its list of approved medicines for public services
France has amended its official list of medicines approved for use by public bodies and services, through an order dated 12 October 2026 and published on 30 October 2026. The detailed changes are in an annex that is not part of the text provided. The order follows a December 2025 opinion from the Haute Autorité de santé's transparency commission on the medicine EZMEKLY, which assesses whether medicines should be reimbursed.
What does it mean?
The list of medicines that public bodies and services are allowed to use has been changed. The specific medicines added or removed are in an annex that is not included here, so the exact changes cannot be checked from this text.
Who is affected?
Public bodies and services that buy or use the medicines on this approved list, and the companies that make them.